Abstract-Four uterine-contractile substances (a, b, c and d) and three uterine contractile substances (a', c' and d') were obtained from the reaction mixture of rat plasma kininogen with the kinin-forming enzyme in rat stomach and the homogenate of the rat stomach with 0.2% acetic acid, respectively.
Abstract-Four uterine-contractile substances (a, b, c and d) and three uterine contractile substances (a', c' and d') were obtained from the reaction mixture of rat plasma kininogen with the kinin-forming enzyme in rat stomach and the homogenate of the rat stomach with 0.2% acetic acid, respectively.
By high performance liquid chromatography with a Zorbax ODS reversed-phase column, the retention times of materials a, c and d were found to be equal to those of materials a', c' and d', and they were not equal to those of kallidin, methionyl-lysyl-bradykinin (MLBK) and bradykinin (BK). The retention time of material b was equal to that of BK. The uterine-contractile activities of the materials a, b, c, d, a', c' and d' were all abolished by chymotrypsin, but not by trypsin treatment. These materials all relaxed the isolated rat duodenum in the presence of atropine, dibenamine, diphenhydramine and propranolol, and they produced a fall in rabbit blood pressure after administration of atropine, dibenamine and propranolol.
The content ratios of a: b: c: d and a': c': d' were 4: 4: 67: 25 and 65: 19: 16, respectively, as calculated from the uterine contractile activities of these materials.
In previous papers, we reported the existence of the bradykinin (BK)-like peptide (P1) in the homogenate of rat stomach with 0.2% acetic acid (1, 2). P1 was distinct from kallidin, methionyl-lysyl-bradykinin (MLBK) and BK (1 ) . We reported the existence of four uterine-contractile active substances (materials a, b, c and d) in the reaction mixture of rat plasma kininogen with the kinin-forming enzyme (pH optimum of 4.8) in rat stomach (3) (4) (5) (6) . Materials a, c and d were also distinct from kallidin, MLBK, BK, neurotensin and material b was identified with BK (5, 6) . This report describes whether or not P1 is the same as material a. c or d. A part of the resultant suspension was centrifuged at 1,300xg for 10 min, and the supernatant fraction was adjusted to pH 8.0 with 3 N NaOH and assayed with the isolated rat uterus.
Materials and Methods

Homogenation
Preparation of kinin-forming enzyme (KFE): Male Wistar rats were killed by a blow on the head. Blood was flushed from the alimentary tract by intravascular perfusion with 50 ml of heparinized (10 units/ml) Krebs-Hensleit solution followed by 50 ml of heparin-free solution, according to the method of Zeitlin (7, 8) . The stomach was removed and homogenized in 10 vol. of cold distilled water. The homogenate was adjusted to pH 2.0 with 3 N HCI, incubation was carried out for 20 min at 37'C to abolish the kininase activity, and then pH was adjusted to 7.0 with 3 N NaOH. After centrifugation at 30,000 x g for 60 min, the supernatant fraction was lyophilized and used as the KFE preparation.
Preparation of rat plasma kininogen (KGN): Blood was collected by heart puncture of ether-anesthetized rats into a polyethylene syringe containing 3.1% sodium citrate solution (one part to nine parts of blood), through a siliconized needle, After centri fugation at 1 ,300 x g for 30 min, the plasma was transferred to a polyethylene tube vvith polyethylene pipets and heated for 30 min at 60°C. The denatured plasma was adjusted to pH 2.0 with 3 N HCI, incubated for 20 min at 37'C, and then the pH was adjusted to 7.0 with 3 N NaOH. After dialysis against distilled water for 48 hr at 4°C, the dialysate was centrifuged at 10,000xg for 30 min, and then the supernatant fraction was lyophilized and used as the KGN preparation. The KG N preparation was capable of yielding 200 ng of BK equivalent per mg by trypsin treatment.
Generation of kinin from KGN by KFE: The incubation was carried out using a mixture of 14 ml of KGN solution (50 mg/ml) dissolved in 0.05 M phosphate buffer (pH 4.8) and 14 ml of the KFE preparation (5 mg; ml) dissolved in the same buffer for 16 hr at 37°C. The reaction was terminated by boiling for 5 min. A part of the resultant suspension was centrifuged at 1 ,300 x g for 10 min, and the supernatant fraction was adjusted to pH 8.0 with 3 N NaOH and assayed with the isolated rat uterus.
Extraction procedure:
The suspensions containing the uterine-contractile activity (5.6 and 108 /cg BK equivalent on assay with the isolated rat uterus in the presence of atropine and dibenamine) derived from the homogenate of rat stomach and the reaction mixture of KGN with KFE were adjusted to pH 2.0 with 3 N HCI and saturated with NaCl. The suspensions of the different origins were extracted separately with n butanol and distilled water, according to the method described previously (5) .
Chromatographic procedure:
The pre parations containing the rat uterine-con tractile activity from the homogenate of rat stomach and the reaction mixture of KGN with KFE, obtained from the extraction procedure, were submitted separately to gradient and equilibrium chromatography with SP-Sephadex C-25 columns by the method described previously (1 ), and gel chromatography (HPLC) with a Zorbax ODS reversed-phase column was performed ac cording to the method described previously (5) .
Enzymatic treatment: Digestions with trypsin and chymotrypsin were carried out by incubating 1 mg of the preparation containing the uterine-contractile activity (0.1 ;cg BK equivalent) with 0.2 ml of enzyme solution (1 mg/ml in distilled water) at 37°C, pH 8.0, for 20 min. The reactions were terminated by boiling for 5 min. After centrifugation at 700xg for 10 min, the supernatant fractions were assayed with the isolated rat uterus.
Biological procedure:
The following isolated tissue preparations were used: the uterus (induced estrus, estradiol 40,000 !U/kg , i.m., 16-20 hr prior to sacrifice) and the duodenum from rats weighing 120-200 g. The tissues were suspended in a bath filled with aerated physiological solutions. De Jalon's solution containing atropine (10-6 g/ ml) and dibenamine (10-7 g/ml) was used as the bathing medium for the rat uterus, and a solution containing additional diphenhydra mine (10-8 g/ml) and propranolol (10-8 g/ ml) was used to suspend the rat duodenum at 30°C. The blood pressure was recorded from the carotid artery of urethanized (1 The preparations containing these uterine contractile activities were submitted to the extraction procedure. Gradient chromatography on SP Sephadex C-25: Linear gradient chromato graphy was carried out with the preparations (4.2 and 81 leg BK equivalent on assay with the isolated rat uterus in the presence of atropine and dibenamine) derived from the homogenate of rat stomach and the reaction mixture of KGN with KFE, obtained from the extraction procedure. As shown in Fig. 1 , the peaks of uterine-contractile activity were both detected in fraction no. 23. of the extracts obtained from the homogenate of the rat stomach and the reaction mixture of the KGN preparation with the KFE preparation. The lyophilized pre parations (4.2 and 82 pg equivalents on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-' g/ml dibenamine) from the homo genate of rat stomach and the reaction mixture of the KGN preparation with the KFE preparation, obtained from the extraction procedure, were dissolved in distilled water and applied to a 2.5x46 cm SP-Sephadex C-25 column. The column was washed with 1500 ml of distilled water and then developed with a linear gradient of ammonium formate solution, pH 5.4 (0-0.4 M). The flow rate was 45 ml/hr. Part of each fraction to be assayed was dissolved in 0.9°°/C) saline, and the resultant solution was tested with the isolated rat uterus in the presence of 10 6 g/ml atropine and 10 ' g/ml dibenamine. The open circles show the elution pattern of the preparation derived from the homogenate of rat stomach. The closed circles show the elution pattern of the preparation derived from the reaction mixture of the KGN preparation with the KFE preparation. The lyophilized preparations (3.8 and 56 tig BK equivalents on assay with the isolated rat uterus in the presence of 10 6 g/ml atropine and 10-' g/ml dibenamine) derived from the homogenate of the rat stomach and the reaction mixture of the KGN preparat on with the KFE preparation, obtained from gradient chromatography, was applied to a 1 .3 x 1 4 cm SP-Sephadex C-25 column. The elution buffer was 0.05 M Tris-HCI buffer (pH 8.0) con taining 0.08 M NaCI. The flow rate was 6 ml/hr. Fractions of 6 ml each were collected, and a part of each fraction was tested with the isolated rat uterus in the presence of 10.6 g/ml atropine and 10-' g/ml dibenamine. In Panel A, the open circles show the elution pattern of the preparation derived from the homogenate of the rat stomach, and the closed circles show the elution pattern of the preparation derived from the reaction mixture of the KGN preparation with the KFE Preparation.
Panel B shows the elution pattern of the standard materials 1, BK: 2, MLBK, and 3, kallidin (60, 400 and 300 pg, respectively). The peaks of uterine contractile activity were both detected in fraction no. 30 (Fig. 3) .
HPLC: The preparations containing the rat uterine-contractile activity, obtained from gel chromatography, were submitted to H PLC with a Zorbax ODS reversed-phase column. In Fig. 4 Each fraction was assayed with the isolated rat uterus in the presence of atropine and dibenamine. As shown in Panels C and E, the regions con taining the uterine-contractile activity were detected. In Panel C, the uterine-contractile activities of materials a', c' and d' derived from the homogenate of rat stomach con tained in fractions no. The preparations (3.5 and 3 ;.'g BK equivalents on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-' g/ml dibenamine) derived from the homogenate of rat stomach and the reaction mixture of the KGN preparation with the KFE preparation, obtained from equilibrium chromato graphy, were dissolved in 0.2 N acetic acid and applied to a 2.6x89 cm Sephadex G-25 column. The flow rate was 14 ml/hr. Fractions of 10 ml each were collected, lyophilized, and a part of each fraction was dissolved in 0.9% saline. The resultant solution was assayed with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-' g/ml The preparations (1 and 25 ag BK equivalents on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10' g/ml dibenamine, respectively) derived from the homogenate of rat stomach , the reaction mixture of the KGN preparation with the KFE preparation , and standard materials (8 ug each) were dissolved in distilled water, and they were applied to a Zorbax ODS reversed-phase column (two columns, each 25 cm long, joined in series). The mobile phase was 0 .05 M potassium dihydrogen phosphate (pH 2.5)-acetonitrile (8:2). The flow rate was 0.6 ml/min. Ultraviolet detection was carried out at 220 nm. Fractions of 1.8 ml each were collected, adjusted to pH 7.0 with 3 N NaOH , lyophilized, and a part of each preparation was assayed with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-' g/ml dibenamine. Panel A shows the elution pattern of the standard materials: kallidin, MLBK, BK and neurotension, detected at 220 nm (0.32 a.u .f.s.). Panels B and D show the chromatographic profile of the preparations derived from the homogenate of rat stomach and the reaction mixture of the KGN preparation with the KFE preparation , obtained from gel chromatography, detected at 220 nm (0.64 and 2.56 a.u.f.s.), respectively. Panels C and E show the distribution of uterine-con tractile activities corresponding to Panels B and D, respectively.
The biologically active substances detected by assay with the rat uterus are indicated by a' , c', d', a, b, c and d. presence of atropine, debenamine, diphen hydramine and propranolol;
and they pro duced a fall in the rabbit blood pressure (0.01, 0.05, 0.05, 0.05, 0.01, 0.2, 0.05 and 0.05 /ig/kg BK equivalent, respectively) after administration of atropine, dibenamine and propranolol (data not shown).
The pharmacological effects of P1 as shown in the previous paper (1) can probably be ascribed to the sum total of the activities of materials a', c' and d'.
Discussion
We reported the existence of the rat uterine-contractile active substance (P1) in the homogenate of rat stomach with 0 .2% acetic acid (1 ) . P1 contracted the isolated rat uterus in the presence of atropine and dibenamine, relaxed the isolated rat duodenum in the additional presence of diphenhydramine and propranolol, and lowered the rabbit blood pressure after administration of atropine, dibenamine and propranolol.
The uterine-contractile activity of P1 is abolished by chymotrypsin, but not by trypsin treatment (1, 2). The retention time of P1 on equilibrium chromatography with SP-Sephadex C-25 column is different from those of kallidin, MLBK and BK. From the results described above, P1 was classified as a biologically BK-like peptide derived from the rat stomach which is distinct from kallidin, MLBK and BK (1). and dibenamine.
From the results described above, the pharmacological effects of P1 as shown in the previous paper (1) can pro bably be ascribed to the sum total of the activities of materials a', c' and d'.
We reported the existence of the kinin forming enzyme (KFE) in the rat stomach (2), and the KFE has characteristics similar to cathepsin D with respect to the specific inhibitors and optimum pH (3, 4 Roffman and Greenbaum (9) reported that not only cathepsin D but also trypsin releases kinins from leukokininogen. Okamoto and Greenbaum (10, 11) reported that high concentration of trypsin generates T-kinin (Ileu-Ser-bradykinin) from rat plasma and that T-kinin may be cleaved from leukokininogen or a hitherto undescribed kininogen (T-kininogen) in rat plasma. It will be of interest to investigate whether the KFE in the rat stomach generates the kinins from HMW or LMW kininogens, the leuko kininogen or T-kininogen.
As shown in Fig. 4 , on HPLC with a Zorbax ODS reversed-phase column, the retention times of materials a', c' and d' derived from the homogenate of rat stomach were observed to match those of materials a, c and d derived from the reaction mixture of KGN with KFE, but not matched to those of kallidin, MLBK, BK and neurotensin. The retention time of material b was observed to match that of BK. From the HPLC results described above, materials a', c' and d' were found to be identical to materials a, c and d, respectively.
Material a' was the major substance (65%) in the homogenate of rat stomach; however, it was only 4% in the reaction mixture of KGN with KFE. Materials c and d were the major substances (67 and 25%) in the reaction mixture of KGN with KFE, but they were not the major substances in the homogenate of rat stomach. The difference in content ratio of the materials in the homogenate of rat stomach and in the reaction mixture of KGN with KFE seems to be because the KFE mainly produces materials c and d.
In this study, we reported the existence of three biologically BK-like peptides (materials a', c' and d') that were different from kallidin, MLBK, BK and neurotensin in the homo genate of rat stomach with 0.2% acetic acid.
We purpose that mainly one biologically 13K-like peptide, material a', is usually relevant to the function of the rat stomach, and additionally, in some physiological or pathological conditions, the other BK-like peptides (materials c' and d') produced by the KFE in the rat stomach are relevant to the function of the stomach.
Erspamer and Melchiorri (12) presented the concept of a skin-gut-brain peptide triangle, i.e., the various peptide families of the amphibian skin exist as their counter parts in mammalian gut and brain (13). Materials a', c' and d' are possible candidates as biologically BK-like peptides in the gastrointestinal tract.
